Formulated for use with multiplex test methods that can detect SARS-CoV-2, flu A/B, and respiratory syncytial virus (RSV). 

Positive reference material directed against SARS-CoV-2, Flu A/B, and RSV included (5 x1.5 ml @ 5,000 copies/ml). 

Negative reference material directed against the human RNase P gene (5 x 1.5 ml @ 5,000 copies/ml). 

Designed to measure the day-to-day performance of the assay, providing both a positive and a negative reference solution.

Features/Benefits

Non-infectious and replication-deficient enables safe handling in contrast to viral samples

Fully extractable with a real viral protein coat; superior to “naked” transcribed RNA

2-year stability at 2 - 8°C

RUO